We are the best-in-class provider of preclinical pharmacology services for metabolic disorders: obesity, diabetes and cardiovascular diseases.
Specifically we accelerate our client’s drug development efforts by providing efficacy, pharmacodynamic (PD) and pharmacokinetic (PK) studies coupled to relevant research models.
Specialties
preclinical research, metabolic research, diabetes studies
